Grundinformationen
- Standard-SMILES
CC1=CC(=O)C=C2CC[C@@H]3[C@H](CC[C@]4(C)C(=O)CC[C@@H]34)[C@@]12C- InChIKey
PEPMWUSGRKINHX-TXTPUJOMSA-N- Summenformel
- C20H26O2
- Durchschnittliche Molmasse
- 298,4 g/mol
- Monoisotopische Masse
- 298,19328007
Überblick
Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.
Namen und Bezeichner
- Bevorzugter Name
- Atamestane
- IUPAC
- (8R,9S,10S,13S,14S)-1,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
- Englischer Name
- atamestane
- Summenformel
- C20H26O2
- Molmasse
- 298.42
Namen und Synonyme
ATAMESTANE96301-34-7AtamestanoAtamestanum1-Methylandrosta-1,4-diene-3,17-dioneSH-489Androsta-1,4-diene-3,17-dione, 1-methyl-62GA3K28B61-methyl-1,4-androstadiene-3,17-dioneDTXSID30869268SH489RefChem:115401
Weitere Namen anzeigen
Aconitine Impurity 3Norgestrel Impurity 2(8R,9S,10S,13S,14S)-1,10,13-trimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione
DTXCID901519069(1S,2S,10R,11S,15S)-2,3,15-trimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-diene-5,14-dioneAtamestane [INN]Atamestanum [Latin]Atamestano [Spanish]CCRIS 6528UNII-62GA3K28B6(8R,9S,10S,13S,14S)-1,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
Datenbank-Bezeichner
- CAS
96301-34-7- PubChem CID
- 57050
- DTXSID
DTXSID30869268- ChEMBL
CHEMBL2105987- UNII
- 62GA3K28B6
- Nikkaji
- J401.576B
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,9
- Polarare Oberfläche (TPSA)
- 34,1 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 22
- Formalladung
- 0
- Komplexität
- 626
Experimentelle und physikochemische Eigenschaften
DrugsPharmaceuticals -> Listed in ZINC15
Endocrine DisruptorsPotential endocrine disrupting compound
Physikochemische Eigenschaften
- Schmelzpunkt
- 165 · 165-167 °C(Solv: ethyl ether (60-29-7); hexane (110-54-3))
- Siedepunkt
- 443 · 443.0±45.0 °C(Predicted)
- Dichte
- 1.12 · 1.12±0.1 g/cm3(Predicted)
- EPA chemische Informationen
- 1 · 1-Methylandrosta-1,4-diene-3,17-dione (96301-34-7)
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological ClassificationCompounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter4 Anbieter
LGM Pharma1-(800)-881-8210 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
西安齐岳生物科技有限公司400-400-6966-012-012 17778955912 · [email protected]
山东子易医药有限公司13173053288 · [email protected]
Zugehörige Reaktionen
6
Verknüpfte Notizen
Wird geladen…